UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.394

Sortiert nach

Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2 1)

British journal of cancer, 2011-06, Vol.104 (12), p.1862-1868

2011

Link zum Volltext

Verfügbarkeit prüfen

Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival

Annals of oncology, 2012-06, Vol.23 (6), p.1601-1607

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors

Annals of oncology, 2013-01, Vol.24 (1), p.252-257

2013

Link zum Volltext

Verfügbarkeit prüfen

High-risk features in radiation-associated breast angiosarcomas

British journal of cancer, 2013-10, Vol.109 (9), p.2340-2346

2013

Link zum Volltext

Verfügbarkeit prüfen

Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1

Oncogene, 2007-05, Vol.26 (24), p.3473-3481

2007

Link zum Volltext

Verfügbarkeit prüfen

Cell cycle-mediated drug resistance : An emerging concept in cancer therapy

Clinical cancer research, 2001-08, Vol.7 (8), p.2168-2181

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase I Dose-Finding Study of Weekly Docetaxel Followed by Flavopiridol for Patients with Advanced Solid Tumors

Clinical cancer research, 2007-10, Vol.13 (19), p.5841-5846

2007

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma

Annals of oncology, 2008-01, Vol.19 (1), p.86-91

2008

Link zum Volltext

Verfügbarkeit prüfen

Sarcoma Immunotherapy: Past Approaches and Future Directions

Sarcoma, 2014, Vol.2014 (2014), p.391967-13

2014

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face

Cancer, 1999-11, Vol.86 (10), p.2034-2037

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol Administered to Patients With Advanced Gastric Carcinoma

Journal of clinical oncology, 2001-04, Vol.19 (7), p.1985-1992

2001

Link zum Volltext

Verfügbarkeit prüfen

Development of cell-cycle inhibitors for cancer therapy

Current oncology (Toronto), 2009-03, Vol.16 (2), p.36-43

2009

Link zum Volltext

Verfügbarkeit prüfen

Sequential Dependent Enhancement of Caspase Activation and Apoptosis by Flavopiridol on Paclitaxel-treated Human Gastric and Breast Cancer Cells

Clinical cancer research, 1999-07, Vol.5 (7), p.1876-1883

1999

Link zum Volltext

Verfügbarkeit prüfen

Measuring tumor response and shape change on CT: esophageal cancer as a paradigm

Annals of oncology, 2006-06, Vol.17 (6), p.1018-1023

2006

Link zum Volltext

Verfügbarkeit prüfen

UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner

Clinical cancer research, 1998-09, Vol.4 (9), p.2201-2206

1998

Link zum Volltext

Verfügbarkeit prüfen

Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells

Clinical cancer research, 1997-09, Vol.3 (9), p.1467-1472

1997

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Sarcoma Immunotherapy: Past Approaches and Future Directions”

Sarcoma, 2015-01, Vol.2015, p.259817-1

2015

Link zum Volltext

Verfügbarkeit prüfen

The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines

Blood, 1997-12, Vol.90 (11), p.4307-4312

1997

Link zum Volltext

Verfügbarkeit prüfen

Obstruction of BRAF V600E transcription by complementary PNA oligomers as a means to inhibit BRAF-mutant melanoma growth

Cancer gene therapy, 2017-09, Vol.24 (9), p.401

2017

Link zum Volltext

Verfügbarkeit prüfen

Novel trial designs for patients with gastrointestinal stromal tumor

ESMO open, 2024-01, Vol.9 (1), p.102218-102218, Article 102218

2024

Link zum Volltext

Verfügbarkeit prüfen

Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlations

Seminars in oncology, 1996-06, Vol.23 (3), p.316-324

Schwartz, G K

1996

Link zum Volltext

Verfügbarkeit prüfen

A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin

Clinical cancer research, 1997-04, Vol.3 (4), p.537-543

1997

Link zum Volltext

Verfügbarkeit prüfen

Potentiation of Apoptosis by Treatment With the Protein Kinase C-Specific Inhibitor Safingol in Mitomycin C-Treated Gastric Cancer Cells

JNCI : Journal of the National Cancer Institute, 1995-09, Vol.87 (18), p.1394-1399

1995

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan in metastatic colorectal cancer: dose intensification and combination with new agents, including biological response modifiers

Annals of oncology, 2003-01, Vol.14 (suppl-2), p.ii17-ii23

2003

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours

Annals of oncology, 2010-04, Vol.21 (4), p.884-894

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.394

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.918)
Mit Volltextzugriff
(3.813)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.855)
Life Sciences & Biomedicine
(2.408)
Humans
(2.069)
Male
(1.281)
Female
(1.272)
Biological And Medical Sciences
(1.214)
Medical Sciences
(1.012)
Middle Aged
(850)
Adult
(785)
Aged
(637)
Animals
(527)
Physical Sciences
(366)
Oncology
(364)
Adolescent
(318)
Fundamental And Applied Biological Sciences. Psychology
(260)
Cardiovascular System & Cardiology
(258)
Risk Factors
(254)
Pharmacology. Drug Treatments
(237)
Child
(224)
Cardiac & Cardiovascular Systems
(210)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2 1)

Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival

Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors

High-risk features in radiation-associated breast angiosarcomas

Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1

Cell cycle-mediated drug resistance : An emerging concept in cancer therapy

Phase I Dose-Finding Study of Weekly Docetaxel Followed by Flavopiridol for Patients with Advanced Solid Tumors

A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma

Sarcoma Immunotherapy: Past Approaches and Future Directions

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face

Phase II Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol Administered to Patients With Advanced Gastric Carcinoma

Development of cell-cycle inhibitors for cancer therapy

Sequential Dependent Enhancement of Caspase Activation and Apoptosis by Flavopiridol on Paclitaxel-treated Human Gastric and Breast Cancer Cells

Measuring tumor response and shape change on CT: esophageal cancer as a paradigm

UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner

Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells

Corrigendum to “Sarcoma Immunotherapy: Past Approaches and Future Directions”

The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines

Obstruction of BRAF V600E transcription by complementary PNA oligomers as a means to inhibit BRAF-mutant melanoma growth

Novel trial designs for patients with gastrointestinal stromal tumor

Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlations

A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin

Potentiation of Apoptosis by Treatment With the Protein Kinase C-Specific Inhibitor Safingol in Mitomycin C-Treated Gastric Cancer Cells

Irinotecan in metastatic colorectal cancer: dose intensification and combination with new agents, including biological response modifiers

Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours

Suchergebnisse filtern